首页> 外文期刊>The veterinary clinics of North America: small animal practice >Management of attention-deficit disorder and attention-deficit/hyperactivity disorder drug intoxication in dogs and cats. (Special Issue: Common toxicologic issues in small animals.)
【24h】

Management of attention-deficit disorder and attention-deficit/hyperactivity disorder drug intoxication in dogs and cats. (Special Issue: Common toxicologic issues in small animals.)

机译:狗和猫的注意力缺陷障碍和注意力缺陷/多动障碍药物中毒的管理。 (特刊:小动物常见的毒理学问题。)

获取原文
获取原文并翻译 | 示例
           

摘要

Two types of drugs are generally used for treating attention-deficit/hyperactivity disorder or attention-deficit disorder in humans: amphetamines or similar stimulants and the nonamphetamine atomoxetine. We describe the toxicity and treatment of both amphetamines and similar medications and atomoxetine in dogs and cats. Amphetamine intoxication can cause life-threatening stimulatory signs. Treatment is aimed at preventing absorption, controlling the stimulatory signs, and protecting the kidneys; prognosis is generally good. Atomoxetine also has a fast onset of action; stimulatory signs such as hyperactivity and tachycardia are often seen. There are little published data about treatment of atomoxetine toxicity in cats and dogs.
机译:通常使用两种类型的药物来治疗人的注意力缺陷/多动症或注意力缺陷症:苯丙胺或类似的兴奋剂和非苯丙胺阿托西汀。我们描述了苯丙胺和类似药物以及托莫西汀在狗和猫中的毒性和治疗。苯丙胺中毒会引起威胁生命的刺激症状。治疗的目的是防止吸收,控制刺激信号和保护肾脏。预后一般良好。阿托莫西汀也起效快。经常会出现刺激迹象,例如活动过度和心动过速。关于猫和狗对阿托西汀毒性的治疗的公开数据很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号